Day One Biopharmaceuticals

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Funding reportedLast round: Post ipo equity

BiopharmaSouth San Francisco, United States

What company datasets say Day One Biopharmaceuticals raised

Funding, as reported

Reported in all$688Min dollars

Rounds5

Last roundPost ipo equity

Last round dateJul 2024

Investors listed16

Investors who name them

Each firm lists Day One Biopharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Day One Biopharmaceuticals in front of investors. Or tell us what we have wrong.